Ronan W. Gannon joined as Chief Commercial Officer in October 2018. He brings more than 25 years of industry experience across large, midsize and startup life science companies. Before joining EryDel, Ronan led global commercial operations at Radius Health (NASDAQ: RDUS), where he helped transform the company from a late-stage development startup into a fully integrated biopharmaceutical company. Prior to that, Ronan spent ten years at CSL Behring where he held several leadership roles including US Vice President Marketing and North America general management roles in the US and Canada. During his tenure at CSL Behring he launched six orphan drugs. Prior to CSL, Ronan led sales and marketing teams at Zeneca Pharmaceuticals, Wyeth and GlaxoSmithKline across several therapeutic areas including biologicals, oncology, and asthma. He received an MBA from Northeastern University, a BA from the University of Richmond and holds alumni status from the Harvard Business School.